Peripheral blood samples were collected for analysis of inflammation markers, before and after 8 weeks of intervention. The procedures performed for labeling CD3+ (anti-CD3 FITC) and CD4+ (anti-CD4 PerCP-CY5.5) as well as for labeling the specific monoclonal antibodies for the cytokines of interest [anti-interleukin (IL)-8 PE, IL-13 APC, IL-17 PE, IL-6 APC, IL-2 APC, IL-10 PE, tumor necrosis factor (TNF) APC] were previously described.33 (link)
All reagents used in the analyses were from Becton Dickinson, San Diego, CA.